UK drugmaker GSK under fresh pressure to sell consumer arm
Elliott Publishes Letter on GlaxoSmithKline
GSK investor support for spin-off vindicates rejection of Unilever
1ada7361-ac20-4227-b729-0a9fa3eeac60.jpg
Elliott Publishes Letter on GlaxoSmithKline
db23bdda-6d99-4873-9e81-15477b151c81.jpg
GlaxoSmithKline chairman Jonathan Symonds accuses activist
Activist investor Elliott Management demands shake-up of
EX-15.2
Activist investor calls for GSK head Sir Jonathan Symonds to quit
The Curious Case Of Elliott Advisors And GSK: Are Activist
61d225c6-b6d5-4c6f-b28f-77f87d8f893d.jpg
Jonathan Symonds - ERT
IMG 2